Middle cerebral arterial thrombosis in a patient with hypofibrinogenemia, 5 days after rFVIIa and FFP infusion

Clinical and Applied Thrombosis/Hemostasis

Volumn 12, Issue 1, 2006, Pages 111-113

  Patiroglu, Turkan ^a   Karakukcu, Musa ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

FFP; Hypofibrinogenemia; rFVIIa; Thrombosis

Indexed keywords

FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADOLESCENT; ARTICLE; BLOOD CLOTTING TEST; CASE REPORT; CONTRAST ENHANCEMENT; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPOFIBRINOGENEMIA; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE CEREBRAL ARTERY THROMBOSIS; OCCLUSIVE CEREBROVASCULAR DISEASE; PLASMA TRANSFUSION; PRIORITY JOURNAL; SUBDURAL HEMATOMA; TREATMENT OUTCOME; VON WILLEBRAND DISEASE;

ADOLESCENT; AFIBRINOGENEMIA; BLOOD COMPONENT TRANSFUSION; FACTOR VII; FEMALE; HEMATOMA, SUBDURAL; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MAGNETIC RESONANCE ANGIOGRAPHY; RECOMBINANT PROTEINS; VON WILLEBRAND DISEASE;

EID: 32344436263     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960601200119     Document Type: Article

References (10)

1. Ni H, Deis VC, Subbarao S, et al. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 2000;106:385.
2. Bauer KA. Rare hereditary coagulation factor abnormalities. In: Nathan DG, Orkin SH, eds. Nathan and Oski's Hematology in Infancy and Childhood. Philadelphia; WB Saunders, 1998:1660.
3. Melissari E, Monte G, Lindo VS, et al. Congenital thrombophilia among patients with venous thromboembolism. Blood Coag Fibrinolysis 1992;3:749.
4. Supandiman I, Sumantri R. Congenital afibrinogenemia in Hasan Sadikin Hospital. Southeast Asian J Trop Med Public Health 1993;24:267.
5. Dupoy E, Soria C, Molho P, et al. Embolized ischemic lesions of toes in afibrinogenemic patient: Possible relevance to in vivo circulating thrombin. Thromb Res 2001;102:211.
6. Lak M, Keihani M, Elahi F, et al. Bleeding and thrombosis in 55 patients with inherited afibrinogenemia. Br J Haematol 1999;107:204.
7. Peter K, Furlan M, Lammle B. Life-long hemorrhagic diathesis in a young man with unclottable global coagulation tests-congenital afibrinogenemia. Ther Umsch 1999;56:516.
8. Cattaneo M, Bettega D, Lombardi R, et al. Sustained correction of the bleeding time in an afibrinogenaemic patient after infusion of fresh frozen plasma. Br J Haematol 1992;82:388.
9. Green F, Humphries S. Genetic determinants of arterial thrombosis. Baillieres Clin Haematol 1994;7:675.
10. Devecioǧlu Ö, Ünüvar A, Anak S, et al. Pyelolithotomy in patient with Glanzmann thrombastenia and antiglycoprotein IIb/IIIa antibodies: the shortest possible duration of treatment with recombinant activated factor VII and platelet transfusions. Turk J Pediatr 2003;45:64.